StandardX launches with £10M to expand isotope production for medicine and fusion

Deeptech company StandardX has raised £10 million in seed funding to develop its accelerator-based isotope refinery and increase production of rare isotopes used in medicine and energy. The round was led by Vsquared Ventures and East X Ventures , with participation from firstminute capital, UKI2S (the UK Innovation and Science Seed Fund), Brevan Howard Macro Venture and Geometry. Founded in 2025 by Richard Pearson (CEO) and Ross Allen (CTO), both nuclear engineers with experience scaling startup